Biomarkers Of Alzheimer S Disease The Present And The Future

Author : Sylvain Lehmann,Charlotte Elisabeth Teunissen
Publisher : Frontiers Media SA
Page : 220 pages
File Size : 52,8 Mb
Release : 2016-11-10
Category : Electronic book
ISBN : 9782889450411

Get Book

Biomarkers of Alzheimer's Disease: The Present and the Future by Sylvain Lehmann,Charlotte Elisabeth Teunissen Pdf

Alzheimer disease (AD) is a neurodegenerative disorder characterized by significant cognitive deficits, behavioral changes, sleep disorders and loss of functional autonomy. AD represents the main cause of dementia and has become a major public health issue. In addition, the number of patients suffering from AD is growing rapidly as the population ages worldwide. Memory impairment is usually the earliest clinical and core symptom of this disease. The diagnosis at a late clinical stage is relatively easy. However, a delay in the diagnosis is damageable for the handling of patients in terms of optimal medical and social care. The actual interest of the scientific head-ways is to optimize the diagnosis in prodromal stage of the disease and to propose personalized therapeutic solutions to individual patients. New revised AD diagnostic criteria include early alteration of cerebrospinal fluid (CSF) biomarkers: decrease of amyloïd peptides (Aβ42), and increase in tau and phosphorylated-tau (p-tau) protein concentration. This recognition of CSF biological biomarkers for the diagnosis of AD is a major step towards the “molecular” diagnosis and follow-up of the disease. Many issues are however still subject of debate. This e-book provides a comprehensive overview of the state of the art of fluid biomarkers for AD, e.g. which novel biomarkers should be implemented in clinical practice for diagnosis or for monitoring treatment or side effects, which ones are new for AD or related dementias or what is the potential of peripheral blood markers. Moreover, the e-Book provides practical guidelines how to optimally and efficiently develop and validate novel biomarker assays, and to document and control pre-analytical variation.

Author : Suman Dutta,Miriam Sklerov,Charlotte Elisabeth Teunissen,Gal Bitan
Publisher : Frontiers Media SA
Page : 273 pages
File Size : 41,5 Mb
Release : 2023-03-23
Category : Science
ISBN : 9782832518007

Get Book

Trends in biomarkers for neurodegenerative diseases: Current research and future perspectives by Suman Dutta,Miriam Sklerov,Charlotte Elisabeth Teunissen,Gal Bitan Pdf

Author : Ronald Sahyouni,Nolan J Brown,Jefferson William Chen
Publisher : World Scientific
Page : 426 pages
File Size : 51,6 Mb
Release : 2021-12-23
Category : Medical
ISBN : 9789811235122

Get Book

Alzheimer's Disease Decoded: The History, Present, And Future Of Alzheimer's Disease And Dementia (Second Edition) by Ronald Sahyouni,Nolan J Brown,Jefferson William Chen Pdf

This book aims to present, educate and inform individuals about Alzheimer's disease in a comprehensive manner. Its scope ranges from the discovery of the disease, epidemiology and basic biological principles underlying it, to advanced stem cell therapies used in the treatment of Alzheimer's. It adopts a 'global' perspective on Alzheimer's disease, and include epidemiological data and science from countries around the world.Alzheimer's disease is a rapidly growing problem seen in every country around the world. This is the first and only comprehensive book to cover Alzheimer's disease, and includes the most updated literature and scientific progress in the field of dementia and Alzheimer's disease research.Most books on the market that focus on Alzheimer's disease are targeted at caregivers as practical advice on how to deal with loved ones with the disease. This book instead is a comprehensive and popular science book that can be read by anyone with an interest in learning more about the disease.Dr Jefferson Chen MD, PhD, co-author, participated in the world's first surgical clinical trial using shunts to treat Alzheimer's disease. His first-hand involvement in a clinical trial for patients with Alzheimer's disease and experience treating Normal Pressure Hydrocephalus (NPH) which is commonly misdiagnosed as Alzheimer's disease lends a unique perspective.This book with appeal to a wide audience, regardless of their scientific or educational background.

Author : Robert Perneczky
Publisher : Springer Nature
Page : 345 pages
File Size : 53,6 Mb
Release : 2024
Category : Alzheimer's disease
ISBN : 9781071637746

Get Book

Biomarkers for Alzheimer's Disease Drug Development by Robert Perneczky Pdf

Zusammenfassung: This fully updated volume provides an up-to-date and comprehensive overview of the current state of technologies helping to accelerate Alzheimer's disease drug development. Addressing the latest advances in preclinical and clinical research, including new insights into the molecular mechanisms and emerging therapeutic strategies, the book continues by exploring digital biomarkers and advanced neuroimaging analysis which will transform how clinical trials in the Alzheimer's disease field are performed. Written for the highly successful Methods in Molecular Biology series, chapters feature the kind of detailed implementation advice that leads to greater success in the lab or clinic. Authoritative and practical, Biomarkers for Alzheimer's Disease Drug Development, Second Edition seeks to inspire and inform future efforts to develop effective treatments for this devastating disease

Author : Harald Hampel,Maria C. Carrillo
Publisher : Karger Medical and Scientific Publishers
Page : 200 pages
File Size : 48,6 Mb
Release : 2012
Category : Medical
ISBN : 9783805598026

Get Book

Alzheimer's Disease by Harald Hampel,Maria C. Carrillo Pdf

How current biomarkers are modernizing the diagnosis of Alzheimer's disease Expanding knowledge on genetic and epigenetic risk factors is rapidly enhancing our understanding of the complex molecular interactions and systems involved in the pathogenesis of Alzheimer's disease. In this publication, leading experts discuss emerging novel conceptual models of the disease along with advances in the development of surrogate markers that will not only improve the accuracy of diagnostic technologies but also improve the prospects of developing disease-modifying interventions. The novel framework of the disease presented here highlights research on biological markers as well as efforts to validate technologies for early and accurate detection. It also introduces notion of a complex systems dysfunction that extends beyond prevailing ideas derived from the amyloid' or tau' hypotheses. This outstanding publication provides researchers, clinicians, students and other professionals interested in neurodegenerative disorders with a comprehensive update on current trends and future directions in therapy development, with special focus on advances in clinical trial designs.

Author : Chiara Villa
Publisher : MDPI
Page : 442 pages
File Size : 52,5 Mb
Release : 2021-02-05
Category : Science
ISBN : 9783039439034

Get Book

Novel Biomarkers in Alzheimer’s Disease by Chiara Villa Pdf

Alzheimer’s disease (AD) represents the most common form of dementia in the elderly population worldwide. AD is characterized by progressive neurodegeneration that leads to a gradual deterioration of memory and other cognitive functions. Given the global prevalence and impact of AD, there is a critical need to establish biomarkers that can be used to detect AD in individuals before the onset of clinical signs and provide mitigating therapeutics. The aim of this Special Issue is to discuss the current knowledge as well as future perspectives on the role of biomarkers in the screening, diagnosis, treatment and follow-up of AD.

Author : Robert Perneczky
Publisher : Humana
Page : 0 pages
File Size : 44,8 Mb
Release : 2024-03-02
Category : Medical
ISBN : 1071637738

Get Book

Biomarkers for Alzheimer’s Disease Drug Development by Robert Perneczky Pdf

This fully updated volume provides an up-to-date and comprehensive overview of the current state of technologies helping to accelerate Alzheimer’s disease drug development. Addressing the latest advances in preclinical and clinical research, including new insights into the molecular mechanisms and emerging therapeutic strategies, the book continues by exploring digital biomarkers and advanced neuroimaging analysis which will transform how clinical trials in the Alzheimer’s disease field are performed. Written for the highly successful Methods in Molecular Biology series, chapters feature the kind of detailed implementation advice that leads to greater success in the lab or clinic. Authoritative and practical, Biomarkers for Alzheimer’s Disease Drug Development, Second Edition seeks to inspire and inform future efforts to develop effective treatments for this devastating disease.

Author : Maria Teresa Ferretti,Annemarie Schumacher Dimech,Antonella Santuccione Chadha
Publisher : Academic Press
Page : 514 pages
File Size : 44,5 Mb
Release : 2021-07-23
Category : Medical
ISBN : 9780128193457

Get Book

Sex and Gender Differences in Alzheimer's Disease by Maria Teresa Ferretti,Annemarie Schumacher Dimech,Antonella Santuccione Chadha Pdf

Sex and Gender Differences in Alzheimer’s Disease: The Women’s Brain Project offers for the first time a critical overview of the evidence documenting sex and gender differences in Alzheimer’s disease neurobiology, biomarkers, clinical presentation, treatment, clinical trials and their outcomes, and socioeconomic impact on both patients and caregivers. This knowledge is crucial for clinical development, digital health solutions, as well as social and psychological support to Alzheimer’s disease families, in the frame of a precision medicine approach to Alzheimer’s disease.This book brings together up-to-date findings from a variety of experts, covering basic neuroscience, epidemiology, diagnosis, treatment, clinical trials development, socioeconomic factors, and psychosocial support. Alzheimer’s disease, the most common form of dementia, remains an unmet medical need for the planet. Wide interpersonal variability in disease onset, presentation, and biomarker profile make Alzheimer’s a clinical challenge to neuroscientists, clinicians, and drug developers alike, resulting in huge management costs for health systems and society. Not only do women represent the majority of Alzheimer’s disease patients, but they also represent two-thirds of caregivers. Understanding sex and gender differences in Alzheimer’s disease will lead to novel insights into disease mechanisms, and will be crucial for personalized disease management strategies and solutions, involving both the patient and their family. Endorsements/Reviews: "There is a clear sex and gender gap in outcomes for brain health disorders like Alzheimer’s disease, with strikingly negative outcomes for women. This understanding calls for a more systematic way of approaching this issue of inequality. This book effectively highlights and frames inequalities in all areas across the translational spectrum from bench-to-bedside and from boardroom-to-policy and economics. Closing the Brain Health Gap will help economies create recovery and prepare our systems for future global shocks." Harris A. Eyre MBBS, PhD, co-lead, Neuroscience-inspired Policy Initiative, OECD and PRODEO Institute. Instructor in Brain Health Diplomacy, Global Brain Health Institute, UCSF and TCD. "Sex and Gender Differences in Alzheimer's disease is the most important title to emerge on Alzheimer's disease in recent years.This comprehensive, multidisciplinary book is a must read for anyone with a serious interest in dementia prevention, diagnosis, treatment, care, cure and research. Precision medicine is the future of healthcare and this book represents an incredible and necessary resource to guide practice, policy and research in light of the fact that Alzheimer's disease disproportionately affects women. The combination of contributions from the most eminent experts and the most up-to-date research makes this an invaluable resource for clinicians, care providers, academics, researchers and policy makers. Given the complex nature of dementia and the multiple factors that influence risk and disease trajectory the scope of the book is both impressive and important covering sex differences in neurobiological processes, sex and gender differences in clinical aspects and gender differences linked to socioeconomic factors relevant to Alzheimer's disease. If you work in Alzheimer's disease, or indeed other dementias, then Sex and Gender Differences in Alzheimer's disease is a must have for your bookshelf." -- Sabina Brennan, PhD., C.Psychol.,PsSI., National representative for Ireland on Alzheimer Disease International's Medical and Scientific Advisory Panel

Author : Charlotte E. Teunissen,Henrik Zetterberg
Publisher : Humana
Page : 236 pages
File Size : 48,5 Mb
Release : 2022-05-19
Category : Medical
ISBN : 1071613219

Get Book

Cerebrospinal Fluid Biomarkers by Charlotte E. Teunissen,Henrik Zetterberg Pdf

This volume covers the latest methods used in clinical neurochemistry laboratories for both clinical practice and research. Chapters in this book discuss topics such as techniques for cerebrospinal fluid (CSF) collection, pre-analytical processing, and basic CSF analysis; an examination of biomarkers including ELISA and automated immunochemical assays for amyloid and tau markers for Alzheimer’s disease; the analysis of neurofilaments by digital ELISA; and an example of successful novel immunoassay development. In the Neuromethods series style, chapters include the kind of detail and key advice from the specialists needed to get successful results in your laboratory. Cutting-edge and thorough, Cerebrospinal Fluid Biomarkers is a valuable resource for clinicians and researchers to use in CSF labs and CSF courses.

Author : Lisa Scott
Publisher : Unknown
Page : 0 pages
File Size : 43,9 Mb
Release : 2022-09-20
Category : Electronic
ISBN : 1639874003

Get Book

Novel Biomarkers in Alzheimer's Disease by Lisa Scott Pdf

The neurochemical indicators which help in the assessment of risk or the presence of Alzheimer's disease are known as Alzheimer's disease biomarkers. They help in an early diagnosis as well as tracking the progress of the disease in a reliable manner. The analysis of biomarkers becomes vital to the management of this disease since the neuropathologic changes occur years before the symptoms are seen. The most important biomarker used for the detection of Alzheimer's disease is amyloid beta. One of the novel approaches towards research on Alzheimer's disease is the usage of autoantibody. These can be used as both biomarkers and for future treatment. This book elucidates the concepts and innovative models around prospective developments with respect to novel biomarkers in Alzheimer's disease. It will also provide interesting topics for research which interested readers can take up. Researchers and students in this field will be assisted by this book.

Author : Yildiz Dincer
Publisher : Unknown
Page : 128 pages
File Size : 40,8 Mb
Release : 2016-02-08
Category : Science
ISBN : 1632780674

Get Book

Alzheimer's Disease Current and Future Perspectives by Yildiz Dincer Pdf

Introduction to the eBookOver the past few decades global prevalence of Alzheimer¿s disease is increased and it became a major public health problem. Millions of elderly population have been suffering from Alzheimer¿s disease worldwide. Many efforts have been made aiming to prevent Alzheimer's disease due to its rising prevalence, the lack of a curative treatment and its high socio-economic cost. Although the study of Alzheimer's disease is moving ahead rapidly, cause of the disease has not been fully clarified yet. Alzheimer's disease is a slowly progressing brain disorder characterized by loss of synapses and neurons in cerebral cortex and in certain sub-cortical regions which leads to memory impairment, cognitive decline, and eventually death.

Author : Institute of Medicine,Board on Health Sciences Policy,Forum on Neuroscience and Nervous System Disorders
Publisher : National Academies Press
Page : 128 pages
File Size : 42,7 Mb
Release : 2008-01-08
Category : Medical
ISBN : 9780309178280

Get Book

Neuroscience Biomarkers and Biosignatures by Institute of Medicine,Board on Health Sciences Policy,Forum on Neuroscience and Nervous System Disorders Pdf

Biomarkers, or biological markers, are quantitative measurements that offer researchers and clinicians valuable insight into diagnosis, treatment and prognosis for many disorders and diseases. A major goal in neuroscience medical research is establishing biomarkers for disorders of the nervous system. Given the promising potential and necessity for neuroscience biomarkers, the Institute of Medicine Forum on Neuroscience and Nervous System Disorders convened a public workshop and released the workshop summary entitled Neuroscience Biomarkers and Biosignatures: Converging Technologies, Emerging Partnerships. The workshop brought together experts from multiple areas to discuss the most promising and practical arenas in neuroscience in which biomarkers will have the greatest impact. The main objective of the workshop was to identify and discuss biomarker targets that are not currently being aggressively pursued but that could have the greatest near-term impact on the rate at which new treatments are brought forward for psychiatric and neurological disorders.

Author : Kevin Morgan,Minerva M. Carrasquillo
Publisher : Springer Science & Business Media
Page : 257 pages
File Size : 52,7 Mb
Release : 2013-06-22
Category : Medical
ISBN : 9781461473091

Get Book

Genetic Variants in Alzheimer's Disease by Kevin Morgan,Minerva M. Carrasquillo Pdf

Alzheimer’s Disease is the most common form of dementia. The disease is characterised by the loss of synapses and neurons in the cerebral cortex and certain subcortical regions. In the last three years, the genetics of Alzheimer’s Disease has made significant advances; in fact, one could argue more than in the previous two decades. This has resulted in the identification of nine new genes and perhaps more importantly the realization that new pathways could be involved in the pathogenesis of Alzheimer’s. These new pathways are now legitimate targets for therapeutic intervention, which can possibly lead to treatment or a possible cure. The aim of this book is to put all of the recent genetic data on these new genes into context. Different genetic variants will be discussed, as well as biomarkers and future possibilities. ​

Author : National Academies of Sciences, Engineering, and Medicine,Health and Medicine Division,Board on Health Sciences Policy,Committee on Preventing Dementia and Cognitive Impairment
Publisher : National Academies Press
Page : 181 pages
File Size : 46,7 Mb
Release : 2017-10-05
Category : Medical
ISBN : 9780309459594

Get Book

Preventing Cognitive Decline and Dementia by National Academies of Sciences, Engineering, and Medicine,Health and Medicine Division,Board on Health Sciences Policy,Committee on Preventing Dementia and Cognitive Impairment Pdf

Societies around the world are concerned about dementia and the other forms of cognitive impairment that affect many older adults. We now know that brain changes typically begin years before people show symptoms, which suggests a window of opportunity to prevent or delay the onset of these conditions. Emerging evidence that the prevalence of dementia is declining in high-income countries offers hope that public health interventions will be effective in preventing or delaying cognitive impairments. Until recently, the research and clinical communities have focused primarily on understanding and treating these conditions after they have developed. Thus, the evidence base on how to prevent or delay these conditions has been limited at best, despite the many claims of success made in popular media and advertising. Today, however, a growing body of prevention research is emerging. Preventing Cognitive Decline and Dementia: A Way Forward assesses the current state of knowledge on interventions to prevent cognitive decline and dementia, and informs future research in this area. This report provides recommendations of appropriate content for inclusion in public health messages from the National Institute on Aging.

Author : National Academies of Sciences, Engineering, and Medicine,Division of Behavioral and Social Sciences and Education,Committee on Population
Publisher : National Academies Press
Page : 409 pages
File Size : 42,6 Mb
Release : 2018-07-21
Category : Social Science
ISBN : 9780309474108

Get Book

Future Directions for the Demography of Aging by National Academies of Sciences, Engineering, and Medicine,Division of Behavioral and Social Sciences and Education,Committee on Population Pdf

Almost 25 years have passed since the Demography of Aging (1994) was published by the National Research Council. Future Directions for the Demography of Aging is, in many ways, the successor to that original volume. The Division of Behavioral and Social Research at the National Institute on Aging (NIA) asked the National Academies of Sciences, Engineering, and Medicine to produce an authoritative guide to new directions in demography of aging. The papers published in this report were originally presented and discussed at a public workshop held in Washington, D.C., August 17-18, 2017. The workshop discussion made evident that major new advances had been made in the last two decades, but also that new trends and research directions have emerged that call for innovative conceptual, design, and measurement approaches. The report reviews these recent trends and also discusses future directions for research on a range of topics that are central to current research in the demography of aging. Looking back over the past two decades of demography of aging research shows remarkable advances in our understanding of the health and well-being of the older population. Equally exciting is that this report sets the stage for the next two decades of innovative researchâ€"a period of rapid growth in the older American population.